
亚太地区医用胶原蛋白市场预测至 2028 年 - COVID-19 影响和区域分析(按来源(牛、猪等)、产品(明胶、水解胶原蛋白、天然胶原蛋白等)和应用(伤口护理、骨移植、组织支架、软骨修复、止血剂、诊断、血管移植物等)
No. of Pages: 122 | Report Code: TIPRE00024542 | Category: Life Sciences
No. of Pages: 122 | Report Code: TIPRE00024542 | Category: Life Sciences
医用胶原蛋白广泛应用于伤口愈合、组织工程、重建手术、骨移植、和整容手术。它是具有低免疫原性的生物相容性材料。胶原蛋白具有良好的止血特性,促进伤口愈合。胶原蛋白用于细胞培养,因为它支持晶格结构和细胞结合域中的细胞增殖。因此胶原蛋白作为生物材料广泛应用于医疗行业。
正在研究一种含有胶原蛋白的医疗产品来治疗多种疾病。由于其临床和消费者的认可,它被广泛用作医疗材料。基于胶原蛋白的医疗产品,如生物假体心脏瓣膜、动脉替代物、外科手术中使用的缝合线和伤口敷料已被广泛采用。因此,正在进行多项研究以开发新的基于胶原蛋白的医疗产品。例如,2020 年,MPM Medical 启动了 CoMatryx 外科牛胶原蛋白研究。 CoMatryx 外科胶原蛋白粉是一种由 100% I 型牛胶原蛋白制成的软组织修复产品。此外,正在进行研究以发现用于医用生物材料的胶原蛋白的新来源。例如,研究“用于医用生物材料的罗非鱼(Oreochromis aureus)胶原蛋白”发表于 2018 年。研究人员研究了罗非鱼皮作为胶原蛋白替代来源在医用生物材料中应用的潜力。因此,基于胶原蛋白的医疗产品的研究活动的增加可能会在预测期内推动市场的增长。此外,可支配收入的激增、先进技术的引入以及更好的术后护理也增加了进行整容手术的数量。皮肤美容行业的跨国公司一直以印度庞大的人口为目标。根据世界经济论坛的数据,印度可支配收入超过 10,000 美元的家庭数量增加了 20 倍,从 1990 年的 250 万户增加到 2015 年的约 5000 万户。因此,可支配收入的增长使他们能够负担得起高成本的医疗保健程序,如美容、骨科和牙科程序,从而推动市场增长。
亚太地区国家正面临着由于 COVID-19 数量不断增加而带来的挑战阳性患者。当前 COVID-19 大流行的情况促使各国政府主要集中精力遏制 COVID-19 的传播,因此对美容治疗的关注暂时转移。皮肤科诊所、医院和外科中心仅提供紧急服务。此外,韩国和日本等国家的医疗旅游因疫情而下降,对美容行业产生了负面影响,进而影响了亚太地区医用胶原蛋白市场的表现。
亚太地区医用胶原蛋白市场按来源分为牛胶原蛋白、猪胶原蛋白等。牛类细分市场在 2020 年占据最大市场份额,预计在预测期内复合年增长率最高。
按产品划分,亚太地区医用胶原蛋白市场为分为明胶、水解胶原蛋白、天然胶原蛋白等。明胶细分市场在 2020 年占据最大市场份额,预计在预测期内复合年增长率最高。
根据应用情况,亚太地区医用胶原蛋白市场细分为止血剂、血管移植物、组织支架、软骨修复、伤口护理、骨移植、诊断等。伤口护理细分市场在 2020 年占据最大市场份额。然而,预计骨移植细分市场在预测期内的复合年增长率最高。
与本亚太医用胶原蛋白报告相关的一些主要和二手来源市场包括世界经济论坛、澳大利亚健康与福利研究所 (AIHW) 和经济合作与发展组织 (OECD)。
< /p>
Strategic insights for Asia Pacific Medical Collagen involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 118.73 Million |
Market Size by 2028 | US$ 188.51 Million |
Global CAGR (2021 - 2028) | 6.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 来源
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Medical Collagen refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Medical Collagen Market is valued at US$ 118.73 Million in 2021, it is projected to reach US$ 188.51 Million by 2028.
As per our report Asia Pacific Medical Collagen Market, the market size is valued at US$ 118.73 Million in 2021, projecting it to reach US$ 188.51 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.
The Asia Pacific Medical Collagen Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Collagen Market report:
The Asia Pacific Medical Collagen Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Collagen Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Collagen Market value chain can benefit from the information contained in a comprehensive market report.